CORRESP Filing
BriaCell Therapeutics Corp.
Date: Jan. 8, 2026 · CIK: 0001610820 · Accession: 0001493152-26-000961
AI Filing Summary & Sentiment
File numbers found in text: 333-292388
Show Raw Text
CORRESP 1 filename1.htm BriaCell Therapeutics Corp. Suite 300 - 235 15th Street West Vancouver, BC V7T 2X1 January 8, 2026 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street NE Washington, D.C. 20549 Attention: Daniel Crawford Re: BriaCell Therapeutics Corp. (the "Company") Registration Statement on Form S-1 (the "Registration Statement") File No. 333-292388 Ladies and Gentlemen: The Company hereby withdraws its request for an accelerated effective date of the above-referenced Registration Statement to 5:00 p.m. Eastern Time on January 8, 2026, or as soon as practicable thereafter. In addition, the Company hereby requests that the effective date of the above-referenced Registration Statement be accelerated to 5:00 p.m. Eastern Time on January 13, 2026, or as soon as practicable thereafter, unless the Company notifies you otherwise prior to such time pursuant to Rule 461 under the Securities Act of 1933, as amended. Once the Registration Statement has been declared effective, please confirm orally that event with our counsel, Sichenzia Ross Ference Carmel LLP, by contacting Christian Lichtenberger, Esq. at (212) 997-0962 or clichtenberger@srfc.law. Very truly yours, /s/ William V. Williams William V. Williams Chief Executive Officer